Revisiting Tricyclic Antidepressants: Understanding the Differences and Advantages for Effective Depression Treatment
While newer antidepressant medications have gained popularity in recent years, tricyclic antidepressants (TCAs) remain an essential treatment option for depression.
Tricyclic antidepressants are first-generation antidepressants that are commonly used to treat Major depressive disorder (MDD), obsessive–compulsive disorder (OCD), and chronic pain (off-label).
Whilst selective serotonin reuptake inhibitors are generally recommended as first-line treatment for MDD, TCAs are often used when patients exhibit a non-response to newer-generation antidepressants.
However, not all TCAs are the same, and clinicians must understand their differences and advantages to treat their patients effectively.
This article will revisit TCAs and explore their pharmacological properties, efficacy, and side effect profiles.
By understanding the unique benefits of each TCA, clinicians can make informed decisions and improve outcomes for their patients with depression.
Fangmann, P., Assion, H. J., Juckel, G., González, C. Á., & López-Muñoz, F. (2008). Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. Journal of Clinical Psychopharmacology, 28(1), 1-4.
Takano H, Arakawa R, Nogami T, Suzuki M, Nagashima T, Fujiwara H, Kimura Y, Kodaka F, Takahata K, Shimada H, Murakami Y, Tateno A, Yamada M, Ito H, Kawamura K, Zhang MR, Takahashi H, Kato M, Okubo Y, Suhara T. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂. Int J Neuropsychopharmacol. 2014 Apr;17(4):553-60